Linaclotide

Chemical formula: C₅₉H₇₉N₁₅O₂₁S₆  Molecular mass: 1,526.736 g/mol  PubChem compound: 16158208

Therapeutic indications

Linaclotide is indicated for:

Moderate to severe irritable bowel syndrome with constipation (IBS-C)

Population group: only adults (18 years old or older)

Linaclotide is indicated for the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation (IBS-C) in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Linaclotide is contraindicated in the following cases:

Mechanical gastrointestinal obstruction

Gastrointestinal obstruction

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: CONSTELLA Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈